Innate inflammation and stroke [manuscripts stemming from the Conference Entitled "Innate Inflammation as the Common Pathway of Risk Factors Leading to Transient Ischemic Attacks and Stroke: Pathophysiology and Potential Interventions" held May 9 - 10, 2010 at the New York Academy of Sciences]
Introduction to innate inflammation: the common denominator of risk factors leading to stroke and TIA -- How inflammation modulates central nervous system vessel activation and provides targets for intervention: a personal perspective -- Innate inflammation as the common pathway of risk factors lead...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | |
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
Boston, Mass.
Blackwell
2010
|
| Schriftenreihe: | Annals of the New York Academy of Sciences Issue
Vol. 1207 |
| Schlagworte: |
Cerebrovascular disease
> Etiology
> Anti-inflammatory agents
> Therapeutic use
> Cerebral ischemia
> Pathophysiology
> Inflammation
> Complications
> Immunological aspects
> Mediators
> Ischemic Attack, Transient
> etiology
> Immunity, Innate
> complications
> Inflammation Mediators
> physiology
> Stroke
> Konferenzschrift
> Schlaganfall
> Entzündung
|
| Online Zugang: | Verlagsangaben Umschlagbild |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Zusammenfassung: | Introduction to innate inflammation: the common denominator of risk factors leading to stroke and TIA -- How inflammation modulates central nervous system vessel activation and provides targets for intervention: a personal perspective -- Innate inflammation as the common pathway of risk factors leading to TIAs and stroke -- Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke -- The challenge of mixed cerebrovascular disease -- Pharmacological modulation of vascular inflammation in atherothrombosis -- NF-[kappa] B and innate immunity in ischemic stroke -- The role of the blood transcriptome in innate inflammation and stroke -- The neurovascular unit, matrix proteases, and innate inflammation -- Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke -- Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy -- Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits -- Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions -- Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses -- Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia -- Impact of innate inflammation in population studies -- Innate inflammation in myocardial perfusion and its implication for heart failure -- Linking infection and inflammation in acute ischemic stroke -- Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? -- Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke -- Acute anti-inflammatory approaches to ischemic stroke -- Combating innate inflammation: a new paradigm for acute treatment of stroke? -- Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. |
|---|---|
| Beschreibung: | Literaturangaben |
| Beschreibung: | VIII, 162 S. Ill., graph. Darst. |
| ISBN: | 1573318132 1-57331-813-2 9781573318136 978-1-57331-813-6 |